Mount Sinai Awarded $6.6 Million From National Institutes of Health to Investigate Treatment for Alopecia Areata in Children
Mount Sinai Health SystemThe Icahn School of Medicine at Mount Sinai Health System is spearheading a collaborative effort to investigate dupilumab as a treatment for children with alopecia areata, a disease that causes extensive hair loss.